Laboratory of Primary Health Care, General Medicine and Health Services Research, School of Medicine, Aristotle University of Thessaloniki, Greece.
MSc Program in Public Health and Health Policy, School of Medicine, Aristotle University of Thessaloniki, Greece.
Public Health. 2024 Apr;229:84-87. doi: 10.1016/j.puhe.2024.01.010. Epub 2024 Feb 26.
Refugees and migrants (R&Ms) exhibited higher risk of COVID-19 infection, and higher mortality rates during the pandemic. Acknowledging these risks, R&Ms early in the pandemic were identified by WHO as a priority vaccination group in need of protection. The aim of this study was to assess the vaccination roll-out and uptake among R&Ms residing in Reception Identification Centers (RICs) and Reception Sites (RSs) in Greece, relative to the general population.
Nationwide observational study.
Retrospective analysis of national vaccination routine data and population census data, collected and triangulated from multiple official/governmental sources. Weekly vaccine roll-out and uptake were calculated for the general Greek population and the R&M population, through the first year of the vaccination programme in Greece (December 2020-December 2021).
Vaccine roll-out among migrants in RICs/RSs started with a 22-week delay, compared to the general population. By the end of the first year of the vaccination programme in Greece in December 2021, the national vaccination uptake among registered R&Ms residing in official reception facilities was 27.3 % for 1st dose and 4.7 % for booster dose; considerably lower compared to the general population (69.5 % uptake for 1st dose, 64.7 % for 2nd dose, and 32.0 % for 3rd dose).
Delayed vaccine roll-out and low vaccine uptake among R&Ms in Greece are signs of low prioritisation and implementation failures in the R&M vaccination strategy. In face of future public health threats, lessons should be learned, and vaccine equity should be insured for all socially vulnerable and high-risk population groups.
难民和移民（R&Ms）在新冠疫情期间感染新冠病毒的风险更高，死亡率也更高。鉴于这些风险，世界卫生组织（WHO）在疫情早期将 R&Ms 确定为需要保护的优先接种群体。本研究旨在评估在希腊的接待识别中心（RIC）和接待点（RS）中居住的 R&Ms 的疫苗接种推出和接种情况，与一般人群进行比较。
全国性观察性研究。
从多个官方/政府来源收集和三角剖分的全国性疫苗接种常规数据和人口普查数据进行回顾性分析。通过希腊疫苗接种计划的第一年（2020 年 12 月至 2021 年 12 月），计算了一般希腊人群和 R&M 人群的每周疫苗推出和接种情况。
与一般人群相比，RIC/RS 中的移民疫苗接种推出延迟了 22 周。到 2021 年 12 月希腊疫苗接种计划的第一年结束时，居住在官方接待设施的登记 R&Ms 的全国疫苗接种第一剂接种率为 27.3%，加强剂接种率为 4.7%；与一般人群相比，这一比例明显较低（第一剂接种率为 69.5%，第二剂接种率为 64.7%，第三剂接种率为 32.0%）。
希腊 R&Ms 的疫苗推出延迟和接种率低表明在 R&M 疫苗接种策略中存在低优先级和实施失败的迹象。在未来面临公共卫生威胁时，应该吸取教训，确保所有社会弱势群体和高风险人群组都能获得疫苗公平。
